Alok Dalal
Stock Analyst at Jefferies
(3.51)
# 2,306
Out of 4,712 analysts
92
Total ratings
59.7%
Success rate
6.8%
Average return
Main Sectors:
Stocks Rated by Alok Dalal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Buy | ₹6,500 → ₹6,400 | ₹5,195 | +23.20% | 6 | Aug 20, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹9,700 → ₹10,350 | ₹8,925 | +15.97% | 5 | Aug 17, 2026 | |
| NSE: EMCURE Emcure Pharmaceuticals Limited | Maintained: Buy | ₹2,100 → ₹2,320 | ₹1,922 | +20.71% | 9 | Aug 11, 2026 | |
| NSE: ENTERO Entero Healthcare Solutions Limited | Maintained: Buy | ₹1,500 → ₹1,800 | ₹1,871 | -3.81% | 7 | Aug 11, 2026 | |
| NSE: GLAND Gland Pharma Limited | Upgraded: Buy | ₹2,080 → ₹3,350 | ₹2,952 | +13.49% | 5 | Aug 11, 2026 | |
| NSE: SAILIFE Sai Life Sciences Limited | Maintained: Buy | ₹1,270 → ₹1,610 | ₹1,674 | -3.83% | 5 | Aug 11, 2026 | |
| NSE: COHANCE Cohance Lifesciences Limited | Maintained: Sell | ₹300.00 → ₹350.00 | ₹443.65 | -21.11% | 2 | Aug 6, 2026 | |
| NSE: MEDANTA Global Health Limited | Maintained: Buy | ₹1,500 → ₹1,660 | ₹1,459 | +13.80% | 6 | Aug 4, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹3,000 → ₹3,220 | ₹2,295 | +40.33% | 7 | Jul 31, 2026 | |
| NSE: CIPLA Cipla Limited | Maintained: Sell | ₹1,170 | ₹1,376 | -14.97% | 8 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,100 → ₹1,700 | ₹1,932 | -11.99% | 4 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,380 → ₹1,500 | ₹1,038 | n/a | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,400 → ₹2,250 | ₹2,101 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,210 → ₹1,100 | ₹1,143 | n/a | 2 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,620 → ₹1,700 | ₹1,462 | n/a | 3 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,350 → ₹1,150 | ₹1,139 | n/a | 3 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹6,280 → ₹6,200 | ₹9,496 | n/a | 2 | May 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹260.00 | ₹222.12 | n/a | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,850 → ₹3,140 | ₹3,542 | n/a | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹890.00 → ₹650.00 | ₹384.40 | n/a | 2 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹860.00 → ₹850.00 | ₹906.75 | n/a | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,260 → ₹2,265 | ₹1,880 | n/a | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | ₹400.00 | ₹397.90 | n/a | 1 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $68 → $12 | $11.88 | n/a | 4 | Jan 30, 2024 |
Alkem Laboratories Limited
Aug 20, 2026
Maintained: Buy
Price Target: ₹6,500 → ₹6,400
Current: ₹5,195
Upside: +23.20%
Apollo Hospitals Enterprise Limited
Aug 17, 2026
Maintained: Buy
Price Target: ₹9,700 → ₹10,350
Current: ₹8,925
Upside: +15.97%
Emcure Pharmaceuticals Limited
Aug 11, 2026
Maintained: Buy
Price Target: ₹2,100 → ₹2,320
Current: ₹1,922
Upside: +20.71%
Entero Healthcare Solutions Limited
Aug 11, 2026
Maintained: Buy
Price Target: ₹1,500 → ₹1,800
Current: ₹1,871
Upside: -3.81%
Gland Pharma Limited
Aug 11, 2026
Upgraded: Buy
Price Target: ₹2,080 → ₹3,350
Current: ₹2,952
Upside: +13.49%
Sai Life Sciences Limited
Aug 11, 2026
Maintained: Buy
Price Target: ₹1,270 → ₹1,610
Current: ₹1,674
Upside: -3.83%
Cohance Lifesciences Limited
Aug 6, 2026
Maintained: Sell
Price Target: ₹300.00 → ₹350.00
Current: ₹443.65
Upside: -21.11%
Global Health Limited
Aug 4, 2026
Maintained: Buy
Price Target: ₹1,500 → ₹1,660
Current: ₹1,459
Upside: +13.80%
Mankind Pharma Limited
Jul 31, 2026
Maintained: Buy
Price Target: ₹3,000 → ₹3,220
Current: ₹2,295
Upside: +40.33%
Cipla Limited
Jul 28, 2026
Maintained: Sell
Price Target: ₹1,170
Current: ₹1,376
Upside: -14.97%
Jul 28, 2026
Maintained: Hold
Price Target: ₹1,100 → ₹1,700
Current: ₹1,932
Upside: -11.99%
Aug 14, 2025
Maintained: Buy
Price Target: ₹1,380 → ₹1,500
Current: ₹1,038
Upside: n/a
Aug 7, 2025
Upgraded: Buy
Price Target: ₹2,400 → ₹2,250
Current: ₹2,101
Upside: n/a
Jul 24, 2025
Maintained: Sell
Price Target: ₹1,210 → ₹1,100
Current: ₹1,143
Upside: n/a
May 31, 2025
Maintained: Hold
Price Target: ₹1,620 → ₹1,700
Current: ₹1,462
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ₹1,350 → ₹1,150
Current: ₹1,139
Upside: n/a
May 18, 2025
Maintained: Hold
Price Target: ₹6,280 → ₹6,200
Current: ₹9,496
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: ₹260.00
Current: ₹222.12
Upside: n/a
Apr 30, 2025
Maintained: Buy
Price Target: ₹2,850 → ₹3,140
Current: ₹3,542
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: ₹890.00 → ₹650.00
Current: ₹384.40
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: ₹860.00 → ₹850.00
Current: ₹906.75
Upside: n/a
Jan 31, 2025
Maintained: Buy
Price Target: ₹2,260 → ₹2,265
Current: ₹1,880
Upside: n/a
Jan 6, 2025
Upgraded: Hold
Price Target: ₹400.00
Current: ₹397.90
Upside: n/a
Jan 30, 2024
Downgraded: Sell
Price Target: $68 → $12
Current: $11.88
Upside: n/a